
Novel peripheral CB1R антагонист, being highly biased toward inhibiting CB1R-induced β-arrestin-2 (βArr2) recruitment over G-protein activation
Novel peripheral CB1R antagonist, being highly biased toward inhibiting CB1R-induced β-arrestin-2 (βArr2) recruitment over G-protein activation
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.